Dyania Health
Dyania’s proprietary Synapsis AI reads an EMR in 0.5 seconds. The time saved is the difference that saves patient lives.
Est 2019
Dyania’s proprietary Synapsis AI reads an EMR in 0.5 seconds. The time saved is the difference that saves patient lives.
Published Jul 15, 2026
The vendor states that throughput scales with additional GPUs. Organizations should verify throughput at peak usage, queuing behavior, latency under load, and cost per screened patient or per trial in pilot tests.
There is limited public review volume on common B2B review platforms for Dyania Health or Synapsis AI. Searches on major review sites did not surface product pages with verified reviews during this research.
Practical implication: publicly visible voice-of-customer evidence is limited. Organizations should conduct reference checks and structured pilots as part of diligence.
Public negative end-user quotes specific to Dyania were not found in accessible sources. The absence of independent negative feedback is a risk signal insofar as it limits available third-party validation, not proof of absence of issues.
Clinical Research News and other trade press provide additional detail about evaluation approaches used in pilots, including descriptions of scoping documents and compute configurations. These reports offer more operational detail than generic marketing pages but are not peer-reviewed methodological papers.
The vendor has received industry awards and accelerator participation listings. Awards and visibility indicate market recognition but do not substitute for controlled outcome studies or independent validation.
Best fit appears to be:
Inferred scale: very large health systems with extensive research infrastructure and substantial research staff.
Decision makers:
End users:
Get a comprehensive analysis of Dyania Health including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Consider alternatives or delay procurement if any of the following apply:
Cleveland Clinic provided statements in press materials indicating that, in pilots, the system met expected milestones for accuracy, usability, and speed to execution and that the user experience was positive. The Cleveland Clinic reported pilot metrics such as identification of an eligible melanoma trial patient in a shorter timeframe compared with manual review and reported specific accuracy metrics for pilot tasks. These reports were provided in Cleveland Clinic materials and related press coverage.
Note: Cleveland Clinic has a reported financial relationship with the vendor; this context should be considered when evaluating endorsements.
Independent of vendor-specific quotes, common areas of buyer skepticism in this market include:
The vendor acknowledges some risk of hallucinations and describes human review as part of its workflow; organizations should quantify the human-in-the-loop effort required in real use.
What is reported:
Pilot metrics reported publicly by Cleveland Clinic and covered in press materials include examples such as:
Critical evaluation / methodology gaps:
Dyania Health is a B2B healthcare AI vendor. Its flagship product, Synapsis AI, is described by the vendor as a system that automates medical chart review / EMR (EHR) review to address clinical and operational questions, including:
Vendor claims include very rapid processing of EMR records (vendor-stated sub-second processing for some tasks) and high reported accuracy metrics (vendor-reported very high accuracy, with variation by task and evaluation design). These performance figures are presented by the vendor and are supported by pilot metrics reported by Cleveland Clinic in press materials; generalizability depends on disease area, protocol complexity, EHR quality, and the specific definition of "accuracy."
Key vendor claims that require scrutiny:
These claims should be validated in scoped pilots with repeatable evaluation methodologies that specify how accuracy is calculated and how human oversight is accounted for.
Dyania targets:
Positioning: vendor materials describe Synapsis AI as an enterprise, behind-the-firewall platform intended to operate within health system security constraints rather than transferring PHI to public cloud services.